Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-based screening of low-affinity compounds.

Robin Carr1, Harren Jhoti

  • 1Astex Technology, 250 Cambridge Science Park, Cambridge, UK CB4 0WE.

Drug Discovery Today
|May 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition.

Cell reports·2025
Same author

Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).

The Cochrane database of systematic reviews·2021
Same author

Fragments: where are we now?

Biochemical Society transactions·2020
Same author

Fragment-based drug discovery using cryo-EM.

Drug discovery today·2019
Same author

Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design.

Drug discovery today·2019
Same author

Discovery of a crystalline sulforaphane analog with good solid-state stability and engagement of the Nrf2 pathway in vitro and in vivo.

Bioorganic & medicinal chemistry·2019
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
See all related articles

Structure-based screening using X-ray crystallography offers a powerful alternative to traditional bioassays for drug lead discovery. This approach excels at identifying and optimizing low-affinity compounds into potent drug leads.

Area of Science:

  • Drug discovery and development
  • Structural biology
  • Biophysics

Background:

  • Conventional bioassays are standard for lead discovery but have limitations.
  • Biophysical methods like X-ray crystallography and NMR are emerging as powerful alternatives.
  • These techniques are crucial for identifying and optimizing novel drug candidates.

Purpose of the Study:

  • To describe emerging technologies in structure-based screening.
  • To highlight the impact of X-ray crystallography on lead discovery.
  • To showcase the advantages of biophysical methods over traditional screening.

Main Methods:

  • Utilizing X-ray crystallography for structure-based screening.
  • Employing Nuclear Magnetic Resonance (NMR) spectroscopy.

Related Experiment Videos

  • Applying structure-guided chemistry for lead optimization.

    • Main Results:

    • X-ray crystallography effectively detects binding of low-affinity, low-molecular-weight compounds.
    • Structure-based approaches enable the transformation of weak binders into potent leads.
    • Emerging technologies promise significant advancements in lead discovery.

    Conclusions:

    • Structure-based screening, particularly using X-ray crystallography, is revolutionizing drug lead discovery.
    • Biophysical methods offer superior capabilities for identifying and optimizing novel drug candidates.
    • These advanced techniques are poised to significantly impact the future of pharmaceutical research.